Search Results - "DeShazo, Mollie"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Pilot Phase II Study of Metronomic Chemotherapy in Combination with Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer by Jones, Benjamin S, Jerome, Mary S, Miley, Deborah, Jackson, Bradford E, DeShazo, Mollie R, Reddy, Vishnu V.B, Singh, Karan P, Brown, Olivia C, Robert, Francisco

    Published in Lung cancer (Amsterdam, Netherlands) (01-04-2017)
    “…Highlights • Metronomic chemotherapy appears tolerable and effective treatment strategy. • Improved PFS and OS. • Plasma biomarkers could potentially…”
    Get full text
    Journal Article
  2. 2

    30 NLR (neutrophil lymphocyte ratio) and PLR (platelet lymphocyte ratio) changes as a predictor of eventual treatment failure and death on nivolumab therapy in renal cell carcinoma by Basu, Arnab, Suri, Yash, Nandagopal, Lakshminarayan, Deshazo, Mollie, Norian, Lyse, Yang, Eddy

    Published in Journal for immunotherapy of cancer (01-11-2020)
    “…BackgroundElevated baseline neutrophil lymphocyte ratios (NLR) are now well established as a poor predictor of survival in renal cell carcinoma (RCC) and other…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

    Treatment of non-small cell lung cancer in the older patient by Ganti, Apar Kishor, deShazo, Mollie, Weir, 3rd, Alva B, Hurria, Arti

    “…Lung cancer is a disease of the elderly, with a median age at diagnosis of 70 years. However, there is a dearth of good quality evidence to guide treatment in…”
    Get more information
    Journal Article
  10. 10

    Phase II study of metronomic chemotherapy (MC) with bevacizumab (B) in patients (Pts) with advanced (Adv) nonsquamous non-small cell lung cancer (NS-NSCLC) by Marquette, Carrie Lee, Grant, Stefan C., DeShazo, Mollie, Reddy, Vishnu, Cantor, Alan, Miley, Debi, Jerome, Mary, Robert, Francisco

    Published in Journal of clinical oncology (20-05-2013)
    “…Abstract only 8057 Background: Targeting vascular endothelial growth factor (VEGF) has shown modest improvement in pts with adv NS-NSCLC. The incorporation…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Intensive anti-inflammatory therapy with dexamethasone in patients with non-small cell lung cancer: effect on chemotherapy toxicity and efficacy by Leggas, Markos, Kuo, Kuei-Ling, Robert, Francisco, Cloud, Gretchen, deShazo, Mollie, Zhang, Ruiwen, Li, Mao, Wang, Hui, Davidson, Steve, Rinehart, John

    Published in Cancer chemotherapy and pharmacology (01-03-2009)
    “…Background Our preclinical and clinical data suggest that pretreatment with dexamethasone 4 days prior to chemotherapy increased the efficacy and decreased the…”
    Get full text
    Journal Article
  15. 15

    Management of squamous cell carcinoma of the head and neck in the elderly: Review and recommendations by Weir, Alva, Ganti, Apar Kishor, deShazo, Mollie, Samant, Sandeep, Hurria, Arti

    Published in Journal of geriatric oncology (01-07-2012)
    “…Abstract In general, the management and reported outcomes for elderly patients with squamous cell carcinoma of the head and neck (SCCHN) have been similar to…”
    Get full text
    Journal Article
  16. 16